Circulating Tumor Cells Market Size, Share & Trends Analysis Report By Application (Clinical/Liquid Biopsy, Research), By Specimen (Bone Marrow, Blood), By Product, By Technology, By End-use, By Region, And Segment Forecasts, 2024 - 2030
- Report ID: 978-1-68038-287-7
- Number of Pages: 120
- Format: Electronic (PDF)
- Historical Range: 2018 - 2023
- Industry: Healthcare
Market Segmentation
- Circulating Tumor Cells Technology Outlook (Revenue in USD Million, 2018 - 2030)
- CTC detection & enrichment methods
- Immunocapture (label-based)
- Positive selection
- Negative selection
- Size-based separation (label-free)
- Membrane-based
- Microfluidic-based
- Density-based separation (label-free)
- Combined methods
- Immunocapture (label-based)
- CTC Direct Detection Methods
- SERS
- Microscopy
- Others
- CTC Analysis
- CTC detection & enrichment methods
- Circulating Tumor Cells Application Outlook (Revenue in USD Million, 2018 - 2030)
- Clinical/ Liquid Biopsy
- Risk Assessment
- Screening and Monitoring
- Research
- Cancer stem cell & tumorogenesis research
- Drug/therapy development
- Clinical/ Liquid Biopsy
- Circulating Tumor Cells Product Outlook (Revenue in USD Million; 2018 - 2030)
- Kits & Reagents
- Blood Collection Tubes
- Devices or Systems
- Circulating Tumor Cells Specimen Outlook (Revenue in USD Million; 2018 - 2030)
- Blood
- Bone Marrow
- Other Body Fluids
- Circulating Tumor Cells End-use Outlook (Revenue in USD Million; 2018 - 2030)
- Research and academic institutes
- Hospital and clinics
- Diagnostic centers
- Circulating Tumor Cells Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- North America Circulating Tumor Cells Market, by Technology
- CTC detection & enrichment methods
- Immunocapture (label-based)
- Positive selection
- Negative selection
- Size-based separation (label-free)
- Membrane-based
- Microfluidic-based
- Density-based separation (label-free)
- Combined methods
- Immunocapture (label-based)
- CTC direct detection methods
- SERS
- Microscopy
- Other
- CTC analysis
- CTC detection & enrichment methods
- North America Circulating Tumor Cells Market, by Application
- Clinical/ liquid biopsy
- Risk assessment
- Screening and monitoring
- Research
- Cancer stem cell & tumorogenesis research
- Drug/therapy development
- Clinical/ liquid biopsy
- North America Circulating Tumor Cells Market, by Product
- Kits & reagents
- Blood collection tubes
- Devices or systems
- North America Circulating Tumor Cells Market, by Specimen
- Blood
- Bone marrow
- Other body fluids
- North America Circulating Tumor Cells Market, by Specimen
- Research and academic institutes
- Hospital and clinics
- Diagnostic centers
- U.S.
- U.S Circulating Tumor Cells Market, by Technology
- CTC detection & enrichment methods
- Immunocapture (label-based)
- Positive selection
- Negative selection
- Size-based separation (label-free)
- Membrane-based
- Microfluidic-based
- Density-based separation (label-free)
- Combined methods
- Immunocapture (label-based)
- CTC direct detection methods
- SERS
- Microscopy
- Other
- CTC analysis
- CTC detection & enrichment methods
- U.S Circulating Tumor Cells Market, by Application
- Clinical/ liquid biopsy
- Risk assessment
- Screening and monitoring
- Research
- Cancer stem cell & tumorogenesis research
- Drug/therapy development
- Clinical/ liquid biopsy
- U.S. Circulating Tumor Cells Market, by Product
- Kits & reagents
- Blood collection tubes
- Devices or systems
- U.S Circulating Tumor Cells Market, by Specimen
- Blood
- Bone marrow
- Other body fluids
- U.S Circulating Tumor Cells Market, by Specimen
- Research and academic institutes
- Hospital and clinics
- Diagnostic centers
- U.S Circulating Tumor Cells Market, by Technology
- Canada
- Canada Circulating Tumor Cells Market, by Technology
- CTC detection & enrichment methods
- Immunocapture (label-based)
- Positive selection
- Negative selection
- Size-based separation (label-free)
- Membrane-based
- Microfluidic-based
- Density-based separation (label-free)
- Combined methods
- Immunocapture (label-based)
- CTC direct detection methods
- SERS
- Microscopy
- Other
- CTC analysis
- CTC detection & enrichment methods
- Canada Circulating Tumor Cells Market, by Application
- Clinical/ liquid biopsy
- Risk assessment
- Screening and monitoring
- Research
- Cancer stem cell & tumorogenesis research
- Drug/therapy development
- Clinical/ liquid biopsy
- Canada Circulating Tumor Cells Market, by Product
- Kits & reagents
- Blood collection tubes
- Devices or systems
- Canada Circulating Tumor Cells Market, by Specimen
- Blood
- Bone marrow
- Other body fluids
- Canada Circulating Tumor Cells Market, by Specimen
- Research and academic institutes
- Hospital and clinics
- Diagnostic centers
- Canada Circulating Tumor Cells Market, by Technology
- North America Circulating Tumor Cells Market, by Technology
- Europe
- Europe Circulating Tumor Cells Market, by Technology
- CTC detection & enrichment methods
- Immunocapture (label-based)
- Positive selection
- Negative selection
- Size-based separation (label-free)
- Membrane-based
- Microfluidic-based
- Density-based separation (label-free)
- Combined methods
- Immunocapture (label-based)
- CTC direct detection methods
- SERS
- Microscopy
- Other
- CTC analysis
- CTC detection & enrichment methods
- Europe Circulating Tumor Cells Market, by Application
- Clinical/ liquid biopsy
- Risk assessment
- Screening and monitoring
- Research
- Cancer stem cell & tumorogenesis research
- Drug/therapy development
- Clinical/ liquid biopsy
- Europe Circulating Tumor Cells Market, by Product
- Kits & reagents
- Blood collection tubes
- Devices or systems
- Europe Circulating Tumor Cells Market, by Specimen
- Blood
- Bone marrow
- Other body fluids
- Europe Circulating Tumor Cells Market, by Specimen
- Research and academic institutes
- Hospital and clinics
- Diagnostic centers
- Germany
- Germany Circulating Tumor Cells Market, by Technology
- CTC detection & enrichment methods
- Immunocapture (label-based)
- Positive selection
- Negative selection
- Size-based separation (label-free)
- Membrane-based
- Microfluidic-based
- Density-based separation (label-free)
- Combined methods
- Immunocapture (label-based)
- CTC direct detection methods
- SERS
- Microscopy
- Other
- CTC analysis
- CTC detection & enrichment methods
- Germany Circulating Tumor Cells Market, by Application
- Clinical/ liquid biopsy
- Risk assessment
- Screening and monitoring
- Research
- Cancer stem cell & tumorogenesis research
- Drug/therapy development
- Clinical/ liquid biopsy
- Germany Circulating Tumor Cells Market, by Product
- Kits & reagents
- Blood collection tubes
- Devices or systems
- Germany Circulating Tumor Cells Market, by Specimen
- Blood
- Bone marrow
- Other body fluids
- Germany Circulating Tumor Cells Market, by Specimen
- Research and academic institutes
- Hospital and clinics
- Diagnostic centers
- Germany Circulating Tumor Cells Market, by Technology
- UK
- UK Circulating Tumor Cells Market, by Technology
- CTC detection & enrichment methods
- Immunocapture (label-based)
- Positive selection
- Negative selection
- Size-based separation (label-free)
- Membrane-based
- Microfluidic-based
- Density-based separation (label-free)
- Combined methods
- Immunocapture (label-based)
- CTC direct detection methods
- SERS
- Microscopy
- Other
- CTC analysis
- CTC detection & enrichment methods
- UK Circulating Tumor Cells Market, by Application
- Clinical/ liquid biopsy
- Risk assessment
- Screening and monitoring
- Research
- Cancer stem cell & tumorogenesis research
- Drug/therapy development
- Clinical/ liquid biopsy
- UK Circulating Tumor Cells Market, by Product
- Kits & reagents
- Blood collection tubes
- Devices or systems
- UK Circulating Tumor Cells Market, by Specimen
- Blood
- Bone marrow
- Other body fluids
- UK Circulating Tumor Cells Market, by Specimen
- Research and academic institutes
- Hospital and clinics
- Diagnostic centers
- UK Circulating Tumor Cells Market, by Technology
- France
- France Circulating Tumor Cells Market, by Technology
- CTC detection & enrichment methods
- Immunocapture (label-based)
- Positive selection
- Negative selection
- Size-based separation (label-free)
- Membrane-based
- Microfluidic-based
- Density-based separation (label-free)
- Combined methods
- Immunocapture (label-based)
- CTC direct detection methods
- SERS
- Microscopy
- Other
- CTC analysis
- CTC detection & enrichment methods
- France Circulating Tumor Cells Market, by Application
- Clinical/ liquid biopsy
- Risk assessment
- Screening and monitoring
- Research
- Cancer stem cell & tumorogenesis research
- Drug/therapy development
- Clinical/ liquid biopsy
- France Circulating Tumor Cells Market, by Product
- Kits & reagents
- Blood collection tubes
- Devices or systems
- France Circulating Tumor Cells Market, by Specimen
- Blood
- Bone marrow
- Other body fluids
- France Circulating Tumor Cells Market, by Specimen
- Research and academic institutes
- Hospital and clinics
- Diagnostic centers
- France Circulating Tumor Cells Market, by Technology
- Italy
- Italy Circulating Tumor Cells Market, by Technology
- CTC detection & enrichment methods
- Immunocapture (label-based)
- Positive selection
- Negative selection
- Size-based separation (label-free)
- Membrane-based
- Microfluidic-based
- Density-based separation (label-free)
- Combined methods
- Immunocapture (label-based)
- CTC direct detection methods
- SERS
- Microscopy
- Other
- CTC analysis
- CTC detection & enrichment methods
- Italy Circulating Tumor Cells Market, by Application
- Clinical/ liquid biopsy
- Risk assessment
- Screening and monitoring
- Research
- Cancer stem cell & tumorogenesis research
- Drug/therapy development
- Clinical/ liquid biopsy
- Italy Circulating Tumor Cells Market, by Product
- Kits & reagents
- Blood collection tubes
- Devices or systems
- Italy Circulating Tumor Cells Market, by Specimen
- Blood
- Bone marrow
- Other body fluids
- Italy Circulating Tumor Cells Market, by Specimen
- Research and academic institutes
- Hospital and clinics
- Diagnostic centers
- Italy Circulating Tumor Cells Market, by Technology
- Spain
- Spain Circulating Tumor Cells Market, by Technology
- CTC detection & enrichment methods
- Immunocapture (label-based)
- Positive selection
- Negative selection
- Size-based separation (label-free)
- Membrane-based
- Microfluidic-based
- Density-based separation (label-free)
- Combined methods
- Immunocapture (label-based)
- CTC direct detection methods
- SERS
- Microscopy
- Other
- CTC analysis
- CTC detection & enrichment methods
- Spain Circulating Tumor Cells Market, by Application
- Clinical/ liquid biopsy
- Risk assessment
- Screening and monitoring
- Research
- Cancer stem cell & tumorogenesis research
- Drug/therapy development
- Clinical/ liquid biopsy
- Spain Circulating Tumor Cells Market, by Product
- Kits & reagents
- Blood collection tubes
- Devices or systems
- Spain Circulating Tumor Cells Market, by Specimen
- Blood
- Bone marrow
- Other body fluids
- Spain Circulating Tumor Cells Market, by Specimen
- Research and academic institutes
- Hospital and clinics
- Diagnostic centers
- Spain Circulating Tumor Cells Market, by Technology
- Sweden
- Sweden Circulating Tumor Cells Market, by Technology
- CTC detection & enrichment methods
- Immunocapture (label-based)
- Positive selection
- Negative selection
- Size-based separation (label-free)
- Membrane-based
- Microfluidic-based
- Density-based separation (label-free)
- Combined methods
- Immunocapture (label-based)
- CTC direct detection methods
- SERS
- Microscopy
- Other
- CTC analysis
- CTC detection & enrichment methods
- Sweden Circulating Tumor Cells Market, by Application
- Clinical/ liquid biopsy
- Risk assessment
- Screening and monitoring
- Research
- Cancer stem cell & tumorogenesis research
- Drug/therapy development
- Clinical/ liquid biopsy
- Sweden Circulating Tumor Cells Market, by Product
- Kits & reagents
- Blood collection tubes
- Devices or systems
- Sweden Circulating Tumor Cells Market, by Specimen
- Blood
- Bone marrow
- Other body fluids
- Sweden Circulating Tumor Cells Market, by Specimen
- Research and academic institutes
- Hospital and clinics
- Diagnostic centers
- Sweden Circulating Tumor Cells Market, by Technology
- Denmark
- Denmark Circulating Tumor Cells Market, by Technology
- CTC detection & enrichment methods
- Immunocapture (label-based)
- Positive selection
- Negative selection
- Size-based separation (label-free)
- Membrane-based
- Microfluidic-based
- Density-based separation (label-free)
- Combined methods
- Immunocapture (label-based)
- CTC direct detection methods
- SERS
- Microscopy
- Other
- CTC analysis
- CTC detection & enrichment methods
- Denmark Circulating Tumor Cells Market, by Application
- Clinical/ liquid biopsy
- Risk assessment
- Screening and monitoring
- Research
- Cancer stem cell & tumorogenesis research
- Drug/therapy development
- Clinical/ liquid biopsy
- Denmark Circulating Tumor Cells Market, by Product
- Kits & reagents
- Blood collection tubes
- Devices or systems
- Denmark Circulating Tumor Cells Market, by Specimen
- Blood
- Bone marrow
- Other body fluids
- Denmark Circulating Tumor Cells Market, by Specimen
- Research and academic institutes
- Hospital and clinics
- Diagnostic centers
- Denmark Circulating Tumor Cells Market, by Technology
- Norway
- Norway Circulating Tumor Cells Market, by Technology
- CTC detection & enrichment methods
- Immunocapture (label-based)
- Positive selection
- Negative selection
- Size-based separation (label-free)
- Membrane-based
- Microfluidic-based
- Density-based separation (label-free)
- Combined methods
- Immunocapture (label-based)
- CTC direct detection methods
- SERS
- Microscopy
- Other
- CTC analysis
- CTC detection & enrichment methods
- Norway Circulating Tumor Cells Market, by Application
- Clinical/ liquid biopsy
- Risk assessment
- Screening and monitoring
- Research
- Cancer stem cell & tumorogenesis research
- Drug/therapy development
- Clinical/ liquid biopsy
- Norway Circulating Tumor Cells Market, by Product
- Kits & reagents
- Blood collection tubes
- Devices or systems
- Norway Circulating Tumor Cells Market, by Specimen
- Blood
- Bone marrow
- Other body fluids
- Norway Circulating Tumor Cells Market, by Specimen
- Research and academic institutes
- Hospital and clinics
- Diagnostic centers
- Norway Circulating Tumor Cells Market, by Technology
- Europe Circulating Tumor Cells Market, by Technology
- Asia Pacific
- Asia Pacific Circulating Tumor Cells Market, by Technology
- CTC detection & enrichment methods
- Immunocapture (label-based)
- Positive selection
- Negative selection
- Size-based separation (label-free)
- Membrane-based
- Microfluidic-based
- Density-based separation (label-free)
- Combined methods
- Immunocapture (label-based)
- CTC direct detection methods
- SERS
- Microscopy
- Other
- CTC analysis
- CTC detection & enrichment methods
- Asia Pacific Circulating Tumor Cells Market, by Application
- Clinical/ liquid biopsy
- Risk assessment
- Screening and monitoring
- Research
- Cancer stem cell & tumorogenesis research
- Drug/therapy development
- Clinical/ liquid biopsy
- Asia Pacific Circulating Tumor Cells Market, by Product
- Kits & reagents
- Blood collection tubes
- Devices or systems
- Asia Pacific Circulating Tumor Cells Market, by Specimen
- Blood
- Bone marrow
- Other body fluids
- Asia Pacific Circulating Tumor Cells Market, by Specimen
- Research and academic institutes
- Hospital and clinics
- Diagnostic centers
- China
- China Circulating Tumor Cells Market, by Technology
- CTC detection & enrichment methods
- Immunocapture (label-based)
- Positive selection
- Negative selection
- Size-based separation (label-free)
- Membrane-based
- Microfluidic-based
- Density-based separation (label-free)
- Combined methods
- Immunocapture (label-based)
- CTC direct detection methods
- SERS
- Microscopy
- Other
- CTC analysis
- CTC detection & enrichment methods
- China Circulating Tumor Cells Market, by Application
- Clinical/ liquid biopsy
- Risk assessment
- Screening and monitoring
- Research
- Cancer stem cell & tumorogenesis research
- Drug/therapy development
- Clinical/ liquid biopsy
- China Circulating Tumor Cells Market, by Product
- Kits & reagents
- Blood collection tubes
- Devices or systems
- China Circulating Tumor Cells Market, by Specimen
- Blood
- Bone marrow
- Other body fluids
- China Circulating Tumor Cells Market, by Specimen
- Research and academic institutes
- Hospital and clinics
- Diagnostic centers
- China Circulating Tumor Cells Market, by Technology
- Japan
- Japan Circulating Tumor Cells Market, by Technology
- CTC detection & enrichment methods
- Immunocapture (label-based)
- Positive selection
- Negative selection
- Size-based separation (label-free)
- Membrane-based
- Microfluidic-based
- Density-based separation (label-free)
- Combined methods
- Immunocapture (label-based)
- CTC direct detection methods
- SERS
- Microscopy
- Other
- CTC analysis
- CTC detection & enrichment methods
- Japan Circulating Tumor Cells Market, by Application
- Clinical/ liquid biopsy
- Risk assessment
- Screening and monitoring
- Research
- Cancer stem cell & tumorogenesis research
- Drug/therapy development
- Clinical/ liquid biopsy
- Japan Circulating Tumor Cells Market, by Product
- Kits & reagents
- Blood collection tubes
- Devices or systems
- Japan Circulating Tumor Cells Market, by Specimen
- Blood
- Bone marrow
- Other body fluids
- Japan Circulating Tumor Cells Market, by Specimen
- Research and academic institutes
- Hospital and clinics
- Diagnostic centers
- Japan Circulating Tumor Cells Market, by Technology
- India
- India Circulating Tumor Cells Market, by Technology
- CTC detection & enrichment methods
- Immunocapture (label-based)
- Positive selection
- Negative selection
- Size-based separation (label-free)
- Membrane-based
- Microfluidic-based
- Density-based separation (label-free)
- Combined methods
- Immunocapture (label-based)
- CTC direct detection methods
- SERS
- Microscopy
- Other
- CTC analysis
- CTC detection & enrichment methods
- India Circulating Tumor Cells Market, by Application
- Clinical/ liquid biopsy
- Risk assessment
- Screening and monitoring
- Research
- Cancer stem cell & tumorogenesis research
- Drug/therapy development
- Clinical/ liquid biopsy
- India Circulating Tumor Cells Market, by Product
- Kits & reagents
- Blood collection tubes
- Devices or systems
- India Circulating Tumor Cells Market, by Specimen
- Blood
- Bone marrow
- Other body fluids
- India Circulating Tumor Cells Market, by Specimen
- Research and academic institutes
- Hospital and clinics
- Diagnostic centers
- India Circulating Tumor Cells Market, by Technology
- South Korea
- South Korea Circulating Tumor Cells Market, by Technology
- CTC detection & enrichment methods
- Immunocapture (label-based)
- Positive selection
- Negative selection
- Size-based separation (label-free)
- Membrane-based
- Microfluidic-based
- Density-based separation (label-free)
- Combined methods
- Immunocapture (label-based)
- CTC direct detection methods
- SERS
- Microscopy
- Other
- CTC analysis
- CTC detection & enrichment methods
- South Korea Circulating Tumor Cells Market, by Application
- Clinical/ liquid biopsy
- Risk assessment
- Screening and monitoring
- Research
- Cancer stem cell & tumorogenesis research
- Drug/therapy development
- Clinical/ liquid biopsy
- South Korea Circulating Tumor Cells Market, by Product
- Kits & reagents
- Blood collection tubes
- Devices or systems
- South Korea Circulating Tumor Cells Market, by Specimen
- Blood
- Bone marrow
- Other body fluids
- South Korea Circulating Tumor Cells Market, by Specimen
- Research and academic institutes
- Hospital and clinics
- Diagnostic centers
- South Korea Circulating Tumor Cells Market, by Technology
- Australia
- Australia Circulating Tumor Cells Market, by Technology
- CTC detection & enrichment methods
- Immunocapture (label-based)
- Positive selection
- Negative selection
- Size-based separation (label-free)
- Membrane-based
- Microfluidic-based
- Density-based separation (label-free)
- Combined methods
- Immunocapture (label-based)
- CTC direct detection methods
- SERS
- Microscopy
- Other
- CTC analysis
- CTC detection & enrichment methods
- Australia Circulating Tumor Cells Market, by Application
- Clinical/ liquid biopsy
- Risk assessment
- Screening and monitoring
- Research
- Cancer stem cell & tumorogenesis research
- Drug/therapy development
- Clinical/ liquid biopsy
- Australia Circulating Tumor Cells Market, by Product
- Kits & reagents
- Blood collection tubes
- Devices or systems
- Australia Circulating Tumor Cells Market, by Specimen
- Blood
- Bone marrow
- Other body fluids
- Australia Circulating Tumor Cells Market, by Specimen
- Research and academic institutes
- Hospital and clinics
- Diagnostic centers
- Australia Circulating Tumor Cells Market, by Technology
- Thailand
- Thailand Circulating Tumor Cells Market, by Technology
- CTC detection & enrichment methods
- Immunocapture (label-based)
- Positive selection
- Negative selection
- Size-based separation (label-free)
- Membrane-based
- Microfluidic-based
- Density-based separation (label-free)
- Combined methods
- Immunocapture (label-based)
- CTC direct detection methods
- SERS
- Microscopy
- Other
- CTC analysis
- CTC detection & enrichment methods
- Thailand Circulating Tumor Cells Market, by Application
- Clinical/ liquid biopsy
- Risk assessment
- Screening and monitoring
- Research
- Cancer stem cell & tumorogenesis research
- Drug/therapy development
- Clinical/ liquid biopsy
- Thailand Circulating Tumor Cells Market, by Product
- Kits & reagents
- Blood collection tubes
- Devices or systems
- Thailand Circulating Tumor Cells Market, by Specimen
- Blood
- Bone marrow
- Other body fluids
- Thailand Circulating Tumor Cells Market, by Specimen
- Research and academic institutes
- Hospital and clinics
- Diagnostic centers
- Thailand Circulating Tumor Cells Market, by Technology
- Asia Pacific Circulating Tumor Cells Market, by Technology
- Latin America
- Latin America Circulating Tumor Cells Market, by Technology
- CTC detection & enrichment methods
- Immunocapture (label-based)
- Positive selection
- Negative selection
- Size-based separation (label-free)
- Membrane-based
- Microfluidic-based
- Density-based separation (label-free)
- Combined methods
- Immunocapture (label-based)
- CTC direct detection methods
- SERS
- Microscopy
- Other
- CTC analysis
- CTC detection & enrichment methods
- Latin America Circulating Tumor Cells Market, by Application
- Clinical/ liquid biopsy
- Risk assessment
- Screening and monitoring
- Research
- Cancer stem cell & tumorogenesis research
- Drug/therapy development
- Clinical/ liquid biopsy
- Latin America Circulating Tumor Cells Market, by Product
- Kits & reagents
- Blood collection tubes
- Devices or systems
- Latin America Circulating Tumor Cells Market, by Specimen
- Blood
- Bone marrow
- Other body fluids
- Latin America Circulating Tumor Cells Market, by Specimen
- Research and academic institutes
- Hospital and clinics
- Diagnostic centers
- Brazil
- Brazil Circulating Tumor Cells Market, by Technology
- CTC detection & enrichment methods
- Immunocapture (label-based)
- Positive selection
- Negative selection
- Size-based separation (label-free)
- Membrane-based
- Microfluidic-based
- Density-based separation (label-free)
- Combined methods
- Immunocapture (label-based)
- CTC direct detection methods
- SERS
- Microscopy
- Other
- CTC analysis
- CTC detection & enrichment methods
- Brazil Circulating Tumor Cells Market, by Application
- Clinical/ liquid biopsy
- Risk assessment
- Screening and monitoring
- Research
- Cancer stem cell & tumorogenesis research
- Drug/therapy development
- Clinical/ liquid biopsy
- Brazil Circulating Tumor Cells Market, by Product
- Kits & reagents
- Blood collection tubes
- Devices or systems
- Brazil Circulating Tumor Cells Market, by Specimen
- Blood
- Bone marrow
- Other body fluids
- Brazil Circulating Tumor Cells Market, by Specimen
- Research and academic institutes
- Hospital and clinics
- Diagnostic centers
- Brazil Circulating Tumor Cells Market, by Technology
- Mexico
- Mexico Circulating Tumor Cells Market, by Technology
- CTC detection & enrichment methods
- Immunocapture (label-based)
- Positive selection
- Negative selection
- Size-based separation (label-free)
- Membrane-based
- Microfluidic-based
- Density-based separation (label-free)
- Combined methods
- Immunocapture (label-based)
- CTC direct detection methods
- SERS
- Microscopy
- Other
- CTC analysis
- CTC detection & enrichment methods
- Mexico Circulating Tumor Cells Market, by Application
- Clinical/ liquid biopsy
- Risk assessment
- Screening and monitoring
- Research
- Cancer stem cell & tumorogenesis research
- Drug/therapy development
- Clinical/ liquid biopsy
- Mexico Circulating Tumor Cells Market, by Product
- Kits & reagents
- Blood collection tubes
- Devices or systems
- Mexico Circulating Tumor Cells Market, by Specimen
- Blood
- Bone marrow
- Other body fluids
- Mexico Circulating Tumor Cells Market, by Specimen
- Research and academic institutes
- Hospital and clinics
- Diagnostic centers
- Mexico Circulating Tumor Cells Market, by Technology
- Argentina
- Argentina Circulating Tumor Cells Market, by Technology
- CTC detection & enrichment methods
- Immunocapture (label-based)
- Positive selection
- Negative selection
- Size-based separation (label-free)
- Membrane-based
- Microfluidic-based
- Density-based separation (label-free)
- Combined methods
- Immunocapture (label-based)
- CTC direct detection methods
- SERS
- Microscopy
- Other
- CTC analysis
- CTC detection & enrichment methods
- Argentina Circulating Tumor Cells Market, by Application
- Clinical/ liquid biopsy
- Risk assessment
- Screening and monitoring
- Research
- Cancer stem cell & tumorogenesis research
- Drug/therapy development
- Clinical/ liquid biopsy
- Argentina Circulating Tumor Cells Market, by Product
- Kits & reagents
- Blood collection tubes
- Devices or systems
- Argentina Circulating Tumor Cells Market, by Specimen
- Blood
- Bone marrow
- Other body fluids
- Argentina Circulating Tumor Cells Market, by Specimen
- Research and academic institutes
- Hospital and clinics
- Diagnostic centers
- Argentina Circulating Tumor Cells Market, by Technology
- Latin America Circulating Tumor Cells Market, by Technology
- Middle East and Africa (MEA)
- Middle East and Africa (MEA) Circulating Tumor Cells Market, by Technology
- CTC detection & enrichment methods
- Immunocapture (label-based)
- Positive selection
- Negative selection
- Size-based separation (label-free)
- Membrane-based
- Microfluidic-based
- Density-based separation (label-free)
- Combined methods
- Immunocapture (label-based)
- CTC direct detection methods
- SERS
- Microscopy
- Other
- CTC analysis
- CTC detection & enrichment methods
- Middle East and Africa (MEA) Circulating Tumor Cells Market, by Application
- Clinical/ liquid biopsy
- Risk assessment
- Screening and monitoring
- Research
- Cancer stem cell & tumorogenesis research
- Drug/therapy development
- Clinical/ liquid biopsy
- Middle East and Africa (MEA) Circulating Tumor Cells Market, by Product
- Kits & reagents
- Blood collection tubes
- Devices or systems
- Middle East and Africa (MEA) Circulating Tumor Cells Market, by Specimen
- Blood
- Bone marrow
- Other body fluids
- Middle East and Africa (MEA) Circulating Tumor Cells Market, by Specimen
- Research and academic institutes
- Hospital and clinics
- Diagnostic centers
- South Africa
- South Africa Circulating Tumor Cells Market, by Technology
- CTC detection & enrichment methods
- Immunocapture (label-based)
- Positive selection
- Negative selection
- Size-based separation (label-free)
- Membrane-based
- Microfluidic-based
- Density-based separation (label-free)
- Combined methods
- Immunocapture (label-based)
- CTC direct detection methods
- SERS
- Microscopy
- Other
- CTC analysis
- CTC detection & enrichment methods
- South Africa Circulating Tumor Cells Market, by Application
- Clinical/ liquid biopsy
- Risk assessment
- Screening and monitoring
- Research
- Cancer stem cell & tumorogenesis research
- Drug/therapy development
- Clinical/ liquid biopsy
- South Africa Circulating Tumor Cells Market, by Product
- Kits & reagents
- Blood collection tubes
- Devices or systems
- South Africa Circulating Tumor Cells Market, by Specimen
- Blood
- Bone marrow
- Other body fluids
- South Africa Circulating Tumor Cells Market, by Specimen
- Research and academic institutes
- Hospital and clinics
- Diagnostic centers
- South Africa Circulating Tumor Cells Market, by Technology
- UAE
- UAE Circulating Tumor Cells Market, by Technology
- CTC detection & enrichment methods
- Immunocapture (label-based)
- Positive selection
- Negative selection
- Size-based separation (label-free)
- Membrane-based
- Microfluidic-based
- Density-based separation (label-free)
- Combined methods
- Immunocapture (label-based)
- CTC direct detection methods
- SERS
- Microscopy
- Other
- CTC analysis
- CTC detection & enrichment methods
- UAE Circulating Tumor Cells Market, by Application
- Clinical/ liquid biopsy
- Risk assessment
- Screening and monitoring
- Research
- Cancer stem cell & tumorogenesis research
- Drug/therapy development
- Clinical/ liquid biopsy
- UAE Circulating Tumor Cells Market, by Product
- Kits & reagents
- Blood collection tubes
- Devices or systems
- UAE Circulating Tumor Cells Market, by Specimen
- Blood
- Bone marrow
- Other body fluids
- UAE Circulating Tumor Cells Market, by Specimen
- Research and academic institutes
- Hospital and clinics
- Diagnostic centers
- UAE Circulating Tumor Cells Market, by Technology
- Saudi Arabia
- Saudi Arabia Circulating Tumor Cells Market, by Technology
- CTC detection & enrichment methods
- Immunocapture (label-based)
- Positive selection
- Negative selection
- Size-based separation (label-free)
- Membrane-based
- Microfluidic-based
- Density-based separation (label-free)
- Combined methods
- Immunocapture (label-based)
- CTC direct detection methods
- SERS
- Microscopy
- Other
- CTC analysis
- CTC detection & enrichment methods
- Saudi Arabia Circulating Tumor Cells Market, by Application
- Clinical/ liquid biopsy
- Risk assessment
- Screening and monitoring
- Research
- Cancer stem cell & tumorogenesis research
- Drug/therapy development
- Clinical/ liquid biopsy
- Saudi Arabia Circulating Tumor Cells Market, by Product
- Kits & reagents
- Blood collection tubes
- Devices or systems
- Saudi Arabia Circulating Tumor Cells Market, by Specimen
- Blood
- Bone marrow
- Other body fluids
- Saudi Arabia Circulating Tumor Cells Market, by Specimen
- Research and academic institutes
- Hospital and clinics
- Diagnostic centers
- Saudi Arabia Circulating Tumor Cells Market, by Technology
- Kuwait
- Kuwait Circulating Tumor Cells Market, by Technology
- CTC detection & enrichment methods
- Immunocapture (label-based)
- Positive selection
- Negative selection
- Size-based separation (label-free)
- Membrane-based
- Microfluidic-based
- Density-based separation (label-free)
- Combined methods
- Immunocapture (label-based)
- CTC direct detection methods
- SERS
- Microscopy
- Other
- CTC analysis
- CTC detection & enrichment methods
- Kuwait Circulating Tumor Cells Market, by Application
- Clinical/ liquid biopsy
- Risk assessment
- Screening and monitoring
- Research
- Cancer stem cell & tumorogenesis research
- Drug/therapy development
- Clinical/ liquid biopsy
- Kuwait Circulating Tumor Cells Market, by Product
- Kits & reagents
- Blood collection tubes
- Devices or systems
- Kuwait Circulating Tumor Cells Market, by Specimen
- Blood
- Bone marrow
- Other body fluids
- Kuwait Circulating Tumor Cells Market, by Specimen
- Research and academic institutes
- Hospital and clinics
- Diagnostic centers
- Kuwait Circulating Tumor Cells Market, by Technology
- Middle East and Africa (MEA) Circulating Tumor Cells Market, by Technology
- North America
Circulating Tumor Cells Market Dynamics
Drivers: Advancements In Chip Technology
The ongoing advancements in chip technology have positively impacted market growth. Cluster chip technology plays a role in capturing the exceptionally rare group of cells, such as CTCs. Isolation of CTCs is a cumbersome process and requires high accuracy. The chip technology not only helps perform precise CTC isolation but also helps overcome the challenges associated with isolation devices like lower sensitivity, high manufacturing costs, and the inability to capture CTCs of all sizes & types developed by key companies. These chips capture individual CTCs that exhibit multiple phenotypes from early- and late-stage cancer in patients. Moreover, the CTCs captured by nanotubes remain viable and can even be cultured. As these chips are transparent, it makes it easier for researchers to stain and study captured CTCs without removing them. Several researchers found that the cluster-chip technique is more efficient than a microfluidic chip, which included isolation of CTCs using antibodies that stick to the special proteins available on the surface of a tumor cell. Owing to advancements in this technology, CTC research is anticipated to witness a growth in demand for tailoring preventive medicine for cancer treatment.
Expanding Applications Of Ctcs
In recent years, CTCs are increasingly being used for determining the prognosis of cancer and helping clinicians decide the type of therapy required for cancer treatment. It can be used for multiple purposes like early detection of cancer, risk assessment of cancer recurrence, guidance for therapies, and continuous monitoring of a patient during cancer treatment. The detection of CTCs in the peripheral blood of patients with cancer acts as a promising diagnostic tool. For instance, quantitation and genomic profiling of CTCs enables cost-effective & accurate noninvasive monitoring of prostate cancer. The detection of CTCs is prognostic for the survival of cancer patients. In addition, Research organizations are constantly engaged in endeavors aimed at developing CTC-based tests, which can prove helpful in cancer diagnosis. This will positively affect the usage & adoption rates of CTCs for cancer diagnosis.
Restraints: Consistency-Related Challenges In Ctc Detection And Enrichment
CTCs can be easily detected in a patient’s bloodstream with the help of different analytical approaches, and it becomes challenging to isolate these cells & quantify their number. CTCs are a group of heterogeneous cells characterized by a diverse range of molecular and biological features. Moreover, lower number of CTCs are detected in the bloodstream as compared to other cancer biomarkers. These factors tend to impede growth to a considerable extent. Concerns related to the reliability and consistency of CTC isolation, as well as the relationship between CTC quantitation & cancer prognosis, are limiting factors affecting the clinical utility of CTCs. Although there is wide availability of several benchtop instruments for analysis and delineating CTCs from other blood cells, it is difficult to characterize CTCs due to substantial phenotypes exhibited by these cells. Considering the differences in immunophenotypical and morphologic characteristics among these cells isolated from the same tissue, CTC detection becomes more challenging, which impedes the adoption of this technique. In addition, CTCs may undergo fragmentation or get damaged, in vitro or in vivo, due to multistep cell preparation processes, thereby causing misinterpretation and subsequent inaccurate detection.
What Does This Report Include?
This section will provide insights into the contents included in this circulating tumor cells market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.
Circulating tumor cells market qualitative analysis
-
Industry overview
-
Industry trends
-
Market drivers and restraints
-
Market size
-
Growth prospects
-
Porter’s analysis
-
PESTEL analysis
-
Key market opportunities prioritized
-
Competitive landscape
-
Company overview
-
Financial performance
-
Product benchmarking
-
Latest strategic developments
-
Circulating tumor cells market quantitative analysis
-
Market size, estimates, and forecast from 2018 to 2030
-
Market estimates and forecast for product segments up to 2030
-
Regional market size and forecast for product segments up to 2030
-
Market estimates and forecast for application segments up to 2030
-
Regional market size and forecast for application segments up to 2030
-
Company financial performance
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
ISO Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
